Bulbitech
World's premier provider of eye and brain data for eyecare professionals, neurologists and researchers
Our Story
Dr. Bjørn Helland-Hansen introducing Bulbitech’s technology and explaining the importance of having a data platform and device available in daily clinical practice that automates and qualifies entrance and functional eye examinations.
Current Tests
Visual Field test
Based on eye movement perimetry our 26-point visual field test screens the patient's visual field in 90 seconds per eye. Measuring the saccadic reaction time, an index for detection of glaucomatous visual field defects, our visual field test quantifies the reaction time towards a peripheral target and detects blind spots
Pupil test
Our pupil test, in four sequences of alternating black and white light patters, simultaneously quantifies both direct and consensual pupillary light reflex in order to detect Relative Afferent Pupil Defect (RAPD)
Ptosis test
Ptosis is a drooping or falling of the upper eyelid and can be one of the first signs of stroke, brain tumour, cancer, neurological disorders or damage to the nerves or muscles supporting the eyelid
Amsler test
Amsler is a test when doctor has suspicion on Macular Degeneration (AMD)
Worth Four Dot test
W4D is a screening test for binocularity. Often made for children.
Upcoming Tests
Acuity test
Eye tracking based acuity testing is objective, doesn’t require operational assistance, and takes just 60 seconds
Nystagmus test
Nystagmus is a “wobbling eye” due to an involuntary eye movement. Nystagmus prevalence is estimated to be 24 persons in a 10.000 population. Currently there is no objective quantification of nystagmus
Strabismus test
Eye deviations are manually assessed, and subjectively interpreted. BulbiCAM will quantify the results of horizontal and vertical eye deviations
Contrast vision test
The contrast vision test is used to quantify to which degree the patient can perceive objects with low contrast. The test requires no communication with the operator. Several diseases like optic neuritis and cataract can reduce contrast vision.
Vergence test
Automated smooth vergence assessment, using virtually 3D stimulus, gives quantified data for near point of convergence and recovery including near pupil reflex
Saccade test
Performed during the visual field test our saccade test measures the peak velocity of horizontal, vertical and oblique saccades to early detect potential neurological diseases, such as Parkinson's disease, dementia or Huntington's disease
Benefits of our technology
- One platform with multiple data parameters about eye and brain health
- Provides objective data of the entrance and functional eye examination
- Replaces manual examinations
- Patient does the work, not the clinician
- Improves accessibility
- Integrates with any third party ophthalmic device
The problems we solve
- Manually performing the entrance and functional eye examination
- Manually inserting test results
- Inefficient clinical workflow
- Subjective interpretation
- Lack of data during clinical decision making
- Lack of research data on eye - brain functionality
Our purpose
Our aim is to become the world’s premier provider of functional eye and eye-brain examination data for eye care and brain care professionals and researchers. We provide eye care and brain care professionals with an eye data platform and a diagnostic support device that automates and quantifies the entrance and functional eye examination for the early detection of ophthalmic and neurological disorders, with the potential to scale in psychology and pharmacology as well.
Our unique BulbiHUB platform and BulbiCAM offers the user multiple entrance and functional eye examinations of which the outcome can be assessed in our platform, making it possible to quickly and objectively add data of the entrance and functional eye examination to your diagnostic workflow. In addition results can be shared amongst clinicians through our telemedicine functionality, facilitating the patient to undergo the examination at a physical location while the eye care professional is working remotely. Ultimately our platform and BulbiCAM requires the patient to do the work, can be operated by anyone and generates objective clinical results needed to fully assess the patient’s comprehensive ophthalmic and neurological condition.
Early detection of functional disorders with a dedicated platform and diagnostic device that replaces the manual examination and saves time
Decentralizing access to entrance and functional examinations providing data that can be accessed remotely and shared amongst peers
Supporting already understaffed eye care professionals to face an increase demand of eye care by providing them with a platform and diagnostic support device in which the patient does the work and can be operated by anyone
Generating objective data and clinical results to improve health outcome and research
BulbiCAM
One diagnostic device automating entrance and functional eye examinations
- 400 FPS eyetracking
- Two screens for independent presentation to each eye
- Accurate timing synchronization
- Calibration free eye tracking test setup
- Individual compensation of refractive errors and head shape
- Patients can be tested standing, sitting or laying
- No table space required
- Expected date of CE-certificate: Q1-2021
More information coming soon. To stay updated please register your interest and subscribe to our newsletter
Our solution
BulbiHUB platform
Platform collects valuable eye and brain data for AI and algorithms to detect patterns for early detection of ophthalmic and neurological disorders. Enabling users to assess clinical outcome of all eye examination tests conducted with our BulbiCAM. Furthermore it is able to process clinical outcome from eye examinations conducted with third party ophthalmic devices
Telemedicine
Data can be shared, tele ophthalmology consultations with patients are possible and third-party devices can be integrated, resulting in a clinical workflow that can continue remotely during pandemic outbreaks
AI [Artificial Intelligence]
Algorithms can be developed
to detect early stage neuro-
ocular dysfunctions and
analyze our collected “big
data” in order to become the
first company that generates
AI analysis on eye tracking
data
Our company
Our Timeline
2015
Funding from public funds and private investors for technology development
2016
Technical R&D development on platform & hardware
Company & software CE-marks based on QMS
Funding from public funds and private investors to complete smaller prototype
2019
Finalist in the DNB Healthcare prize
2020
Bulbitech wins healthcare pitching contest at Oslo Innovation Week
Frozen BulbiCAM prototypes for clinical testing
Our team
Board
ODD HJELMELAND
TOR ULLEBERG
KENT THOMAS HÅGENSTAD RANUM
HARALD FREDRIK ULLTVEIT-MOE
Ophthalmologist
Management team
BÅRD DALHØI
HANS-PETER KURZ
DENNIS HENS
BJØRN A. HELLAND-HANSEN, MD
Clinical Advisory Board
KLAUS A. SJØHAUG
Optometrist/Doctor of Optometry
JOHAN PEL
Associate Professor Neuroscience
HANS VAN DER STEEN
Professor Neuroscience
STIG LARSEN
Professor Controlled Clinical Research Methodology and Statistics
Partners
